2009-11-25 12:47:36 - Osteoporosis Therapeutics - A Global Market Perspective - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Market-Report/osteoporosis-t ..

""Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America, Europe, and Japan. Afflicting millions of people across the world, the potentially life-threatening disease - osteoporosis poses a major clinical challenge to the medical world. Major therapeutic classes currently available include bisphosphonates, Estrogen Replacement Therapy (ERT) drugs, calcitonins and Selective Estrogen Receptor Modulators (SERMs). Parathyroid Hormone (PTH)-based drugs comprise the most recent genre of therapeutics with new bone-forming potential. As osteoporosis is asymptomic, several cases of osteoporosis are detected only after experiencing a fracture.

These and other market data and trends are presented in """"Osteoporosis Therapeutics: A Global Market Perspective"""" by BizAcumen, Inc. Our reports are designed to be most

 

 

comprehensive in geographic coverage and vertical market analyses.""